Tag: pmi

  • PMI Reports Strong Q3 Based on Smoke-Free Surge

    PMI Reports Strong Q3 Based on Smoke-Free Surge

    Today (October 21), Philip Morris International reported strong third-quarter 2025 results, with adjusted diluted earnings per share rising 17.3% to $2.24, while reported EPS increased 13.2% to $2.23. The company said it achieved record smoke-free gross profit, supported by higher volumes and favorable pricing. Net revenues grew 5.9% on an organic basis, and adjusted operating income rose 7.5%, driven by strong performance in smoke-free products, despite a 3.2% decline in cigarette volumes.

    PMI’s smoke-free portfolio continued to expand rapidly, now accounting for 41% of total net revenues and 42% of gross profit. Volumes of smoke-free products rose 16.6%, led by the IQOS heated tobacco line and ZYN nicotine pouches. IQOS strengthened its market share across Europe and Asia, while ZYN’s U.S. offtake surged 39% following its return to full availability. The e-vapor brand VEEV also posted a 91% jump in shipments, solidifying PMI’s diversified presence across smoke-free categories.

    Reflecting this momentum, PMI raised its full-year adjusted EPS guidance and boosted its quarterly dividend by 8.9% to $1.47 per share. CEO Jacek Olczak said the company’s smoke-free business “continues to outgrow the industry by a clear margin,” adding that PMI is “on track to exceed” its 2024–2026 growth targets. Despite regulatory challenges in some markets, the company remains focused on transitioning adult smokers toward smoke-free alternatives and expanding its portfolio in 100 markets worldwide.

  • PMI Launches VEEV in South Africa, Expands Smoke-Free Portfolio

    PMI Launches VEEV in South Africa, Expands Smoke-Free Portfolio

    Philip Morris South Africa (PMSA) launched its VEEV e-cigarette this week, completing the company’s trio of smoke-free products in the country alongside IQOS heated tobacco and ZYN nicotine pouches, according to BizCommunity. This makes South Africa one of just 20 countries globally offering all three categories, underscoring PMSA’s commitment to providing adult smokers with scientifically backed alternatives to combustible cigarettes.

    Jonathan Kwak, Director of Smoke-Free Products at PMSA, said the launch gives “adult smokers more options than before when considering scientifically substantiated alternatives to smoking” and is a critical step toward eliminating cigarette use. PMI says it has invested over $14 billion globally since 2008 in research and development of smoke-free products, which are now available in 97 markets and used by more than 41 million adult consumers worldwide.

    While emphasizing that quitting all tobacco and nicotine remains the best choice, Kwak said that switching entirely to smoke-free products can significantly reduce exposure to harmful chemicals produced by burning tobacco. “With our expanding offering, we aim to accelerate South Africa’s transition to a smoke-free future, aligning with harm-reduction principles already embraced in other public-health fields,” he said.

  • Philip Morris Italia Under Investigation for ‘Smoke-Free’ Language

    Philip Morris Italia Under Investigation for ‘Smoke-Free’ Language

    Italy’s competition authority launched an investigation into Philip Morris Italia for allegedly misleading advertising related to its “smoke-free” electronic cigarettes. The probe, announced today (October 15), centers on the company’s use of phrases such as “a smoke-free future” and “smoke-free products,” which regulators say could mislead consumers into believing the products are harmless.

    The Italian Competition Authority (AGCM), accompanied by financial police, searched two Philip Morris offices in Italy as part of the inquiry. The watchdog said that while these products do not involve combustion, they can still pose health risks and cause addiction.

    “Philip Morris Italia believes it has always acted in full compliance with applicable regulations,” a PMI spokesperson said regarding the proceedings initiated the AGCM. “The company is confident that its communication is factual, truthful, and fully consistent with both Italian and European legislation, which associate the absence of smoke with the absence of combustion. Italian Legislative Decree No. 6/2016, which transposes EU Directive 2014/40/EU, defines in Article 2, paragraph 5, a ‘smoke-free tobacco product’ (‘smokeless tobacco product’ in the English version of the directive) as ‘a tobacco product that does not involve a combustion process.’

    “The pursuit of a smoke-free future has been the primary global objective of Philip Morris International for nearly a decade—an ambition that the Italian affiliates have been working toward for years, alongside an integrated ‘Made in Italy’ value chain involving 44,000 people.

    “The company will continue to cooperate with the Authority throughout the proceedings to demonstrate the full legitimacy of its actions.”

    The move follows similar action in France earlier this year, where Philip Morris was fined €500,000 for promoting its IQOS heated tobacco device as safer under the classification of harm reduction.

  • PMI Responds to Italian Investigation of ‘Smoke-Free’ Language

    PMI Responds to Italian Investigation of ‘Smoke-Free’ Language

    Today (October 15), the Italian Competition Authority (AGCM), accompanied by financial police, searched two Philip Morris offices in Italy as part of the inquiry regarding the company’s use of phrases such as “a smoke-free future” and “smoke-free products” regarding its electronic cigarettes.

    In response, a PMI spokesperson told Tobacco Reporter:

    “With reference to the proceeding initiated yesterday by the Italian Competition Authority (AGCM) concerning the use of the term “smoke-free” in communications related to our corporate vision and our combustion-free products, Philip Morris Italia believes it has always acted in full compliance with applicable regulations. The Company is confident that its communication is factual, truthful, and fully consistent with both Italian and European legislation, which associate the absence of smoke with the absence of combustion. Italian Legislative Decree No. 6/2016, which transposes EU Directive 2014/40/EU, defines in Article 2, paragraph 5, a “smoke-free tobacco product”  (“smokeless tobacco product” in the English version of the Directive) as “a tobacco product that does not involve a combustion process”.

    “The pursuit of a smoke-free future has been the primary global objective of Philip Morris International for nearly a decade—an ambition that the Italian affiliates have been working toward for years, alongside an integrated Made in Italy value chain involving 44,000 people.

    “The Company will continue to cooperate with the Authority throughout the proceeding to demonstrate the full legitimacy of its actions.”

  • Philip Morris to Host Q3 2025 Results Webcast

    Philip Morris to Host Q3 2025 Results Webcast

    Philip Morris International announced it will hold a live audio webcast on Tuesday, October 21, at 9 a.m. ET to discuss its third-quarter and first nine-month results, which will be released at approximately 7 a.m. the same day. The webcast, hosted by CFO Emmanuel Babeau, will feature a review of financial results and a Q&A session with the investment community in listen-only mode. The webcast can be accessed here or via PMI’s Investor Relations App for mobile devices. Slides, script, and recording will be available for one year following the event.

  • PM Japan Announces Two New Launches

    PM Japan Announces Two New Launches

    Philip Morris Japan (PMJ) announced it will launch the IQOS ILUMA i Galaxy Blue Model on October 29, a limited-edition device inspired by the “mysteries and infinite possibilities of the universe.” The ¥6,980 ($46) model features a deep-space blue charger with a starry gradient design. PMJ’s marketing director, Daniel Sevsik, said the edition was created to reinforce IQOS ILUMA i’s image of “innovation and future possibilities.”

    The company will also release its TEREA Clear Regular on October 27, a “smooth and balanced tobacco stick” for the IQOS ILUMA and ILUMA i series. Sevsik said the regular flavor segment has growth potential, as users tend to be more stable than menthol and flavored product consumers. The new variant becomes the sixth regular option in the TEREA lineup.

  • Philip Morris Urges FDA TPSAC to Recommend Continued Modified-Risk Marketing of IQOS

    Philip Morris Urges FDA TPSAC to Recommend Continued Modified-Risk Marketing of IQOS

    Experts from Philip Morris International presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC), according to a PMI press release. The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP).

    The full-day meeting on October 7 was part of the FDA’s customary review of PMI’s request to continue marketing versions of its IQOS heated-tobacco products in the U.S. as modified-risk tobacco products (MRTPs), a necessary step while FDA completes its review of pending applications for IQOS ILUMA (a later version of the IQOS models that are currently authorized by the FDA) to reach and transition even more legal-age adults away from combustible cigarettes.

    “The evidence presented at this meeting, as also noted by the FDA, further supports the agency’s original conclusions that led the FDA to authorize the IQOS system as a modified-risk tobacco product,” said Stacey Kennedy, PMI U.S.’ CEO. “We encourage the FDA to continue efforts to establish a timely scientific review process for smoke-free products—including for IQOS ILUMA, which has been pending FDA review for nearly two years and has globally shown even higher rates of legal-age adults fully switching from combustible cigarettes—that are a better choice for legal-age adults who would otherwise use traditional tobacco products, including combustible cigarettes.”

    Initially granted by the FDA in 2020, the MRTP designation for the IQOS system authorizes PMI to communicate to legal-age consumers that: “AVAILABLE EVIDENCE TO DATE: The IQOS system heats tobacco but does not burn it. This significantly reduces the production of harmful and potentially harmful chemicals. Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals.”

    During the meeting, representatives from PMI and committee members discussed a range of scientific, technical, and consumer-communications topics. The company provided an overview of its responsible marketing practices and presented additional evidence and research demonstrating high levels of complete switching among current legal-age smokers while maintaining low levels of use by unintended populations.

    Addressing committee members, Keagan Lenihan, VP and Chief External Affairs Officer for PMI U.S., said: “CTP’s mission is to make tobacco-related disease and death a part of America’s past. Smoke-free products, like PMI’s IQOS system, play a critical role in helping CTP achieve this mission and provide adults who smoke with a real opportunity to change. The IQOS system, when marketed with the reduced-exposure claim, promotes complete switching from combustible cigarettes.”

  • PMI Head Calls for Partnership and Action at GTNF 2025

    PMI Head Calls for Partnership and Action at GTNF 2025

    Erin Warren, Head of Regulatory and Public Policy at Philip Morris International (PMI US), delivered a powerful keynote at GTNF Brussels, urging urgent reform to accelerate tobacco harm reduction, opening with stark numbers.

    “Cigarette smoking remains the leading cause of preventable death in the United States, taking more than 480,000 lives every year,” she said. “That’s 1,300 people every single day. Globally, the toll exceeds 8 million deaths annually.” She emphasized that behind these statistics are real people: “A mother, a father, a friend, a colleague—each hoping for better options but often finding barriers instead.”

    Central to her message was the “continuum of risk.” Praising the FDA’s pilot program to expedite nicotine pouch applications, she said: “For the first time in a long time, the FDA explicitly acknowledged the continuum of risk. This is the difference between paralysis and progress. While nicotine is addictive, it is not the primary cause of smoking-related disease. Smoke is. Combustion is.

    “Sweden’s long-standing availability of snus has driven smoking rates down to 5.3%, near the smoke-free benchmark. In contrast, Belgium’s ban on nicotine pouches removed regulated, safer alternatives but left the most dangerous products on the market. Smoking rates rose from 19% in 2017 to 21% in 2023.”

    She also addressed widespread misconceptions among healthcare providers: “A recent survey found that 47% of U.S. doctors mistakenly believe nicotine is carcinogenic, and another 19% are unsure. This misinformation traps millions in a cycle of smoking.”

    To move from paralysis to progress, Warren outlined five reforms: elevate public education, increase regulatory transparency, embrace innovation and harm reduction, clear the FDA backlog of nearly half a million stalled applications, and ensure independent oversight. “Regulatory delays create a vacuum filled by illicit products—undermining public health and consumer safety,” she said.

    “Every delay, every unclear decision, every piece of misinformation prolongs the moment when someone might finally step away from cigarettes. When that mother switches, she not only improves her own health—she shows her children that positive change is possible.”

    Closing with a call for partnership and action, Warren urged stakeholders to act decisively.

    “We are not asking regulators to lower standards,” Warren said. “We are asking for standards that are clear, consistent, and anchored in science. The FDA pilot is a promising sign—but it’s just a signpost, not a destination. Let’s build a future where adults have better choices, doctors have better information, and public health has better outcomes.”

  • Taxes Increasing Gap Between Regulatory Intentions and Market Realities

    Taxes Increasing Gap Between Regulatory Intentions and Market Realities

    At the Global Tobacco and Nicotine Forum (GTNF) in Brussels, a panel moderated by Tim Phillips, Managing Director of Tamarind Intelligence, explored how taxation and tariffs are shaping the future of nicotine products in a rapidly evolving market. Speakers included Christa Pelsers (BAT), Stefano Santi (Philip Morris International), and Maria Angelova (Socotab Frana SA).

    In “It’s All About Tax — The Complex World of Excise and Tariffs,” Phillips opened by stressing that “the next few years are going to be vitally important,” as novel products—from vapes to nicotine pouches—continue to disrupt markets. “We’re seeing massive problems around illicit trade and tax collection,” he said, noting that in some countries, “more than half of the market may already be illicit.” The result, he warned, is a growing gap between regulatory intentions and market realities.

    Pelsers highlighted the speed of innovation and the challenges it creates for regulators. “For years, there was no innovation in tobacco, and now we have an explosion of new products—governments are still trying to catch up,” she said. Pelsers argued that taxation must be based on science, not politics, and criticized the European Commission’s fragmented approach: “The Commission is proposing that every member state can adjust its own rates. That makes things even more complex. We need harmonization to ensure fairness and functionality in the single market.”

    She also warned of geopolitical shifts impacting trade. “With U.S. tariffs, China is redirecting exports elsewhere. The EU’s response has been slow. The next few years will reshape who we trust as trading partners,” she said. “And if tax rates are set too high, it will be detrimental to innovation.”

    Santi emphasized that excise tax policy should not only collect revenue but also guide consumers toward less harmful products. “Ten years ago, my job was complexity five; now it’s fifty,” he said. “We need to balance taxation in a way that shifts the market without driving consumers to the black market.” He endorsed differentiated tax levels for different product types, saying, “If you raise taxes too fast, consumers will find cheaper, often illicit alternatives.”

    Santi called for leveraging member state experience to modernize EU tax policy and harmonize definitions. “The directive is a good start, but it’s lagging behind. Treating all products the same is a recipe for failure. Europe needs to protect its economic and manufacturing footprint.”

    Angelova added a perspective from the leaf tobacco sector, calling taxation “one of the quiet architects of humanity.” She warned that poorly designed taxes could devastate rural livelihoods. “Tobacco is an agricultural product that supports families. Nowhere else in the world is raw tobacco subject to excise tax,” she said. “Making local tobacco less affordable than imported tobacco doesn’t help anyone.”

    Angelova stressed the importance of practical implementation: “It’s not just about what we tax—it’s about how. Details make the difference. Track and trace systems are vital to ensure transparency and prevent unfair competition.”

    She concluded by urging policymakers to proceed with caution: “We’re trying to solve too many problems at once. We need to start addressing them one by one. Europe still has many families who rely on tobacco farming. Consumers won’t forget how we handle this.”

    The panel collectively underscored that while excise and tariff reforms are inevitable, their success will depend on nuance, balance, and genuine collaboration with industry to avoid unintended economic and public health consequences.

  • PMI Announces $37M Upgrade to Wilson, N.C. Facility

    PMI Announces $37M Upgrade to Wilson, N.C. Facility

    Philip Morris International’s U.S. businesses today (October 2) announced a $37 million investment in its Wilson, North Carolina, manufacturing facility to expand operations and strengthen its production of smoke-free alternatives. The Wilson factory currently produces HEETS for IQOS 3.0, the only heated tobacco product authorized by the FDA as a modified risk tobacco product (MRTP) with reduced exposure claims. The new investment will add a production line for TEREA, the consumables for IQOS ILUMA, which is awaiting FDA authorization.

    “Our U.S. manufacturing footprint is critical to producing innovative smoke-free alternatives for adult consumers,” said Stacey Kennedy, CEO of PMI U.S. “We’re proud to increase our investment in Wilson and spur further economic growth in the area.”

    Ryan Simons, President of the Wilson Chamber of Commerce, welcomed the expansion, calling it a sign that Wilson is a place where global companies “can grow and thrive.”

    The Wilson facility employs more than 80 full-time staff and plays a key role in PMI U.S.’s strategy to replace cigarettes with smoke-free alternatives. The company has also announced major U.S. investments in Owensboro, Kentucky, and Aurora, Colorado, totaling more than $800 million and expected to create nearly 1,000 direct jobs.